KAISERSLAUTERN, Germany, March 20, 2013 /PRNewswire/ -- pharmaSOL, a Gold member of the Oracle PartnerNetwork, today announced that rapidLIVE, an Oracle Accelerate solution for the Life Sciences industry, is now available in the United States. The Oracle Accelerate rapidLIVE solution is designed with the required components to go-live with a new system in a short timeframe, whilst adhering to the highest industry standards relating to system validation and documentation. The Oracle Accelerate rapidLIVE solution is available for Oracle Clinical, Oracle Remote Data Capture (RDC), Oracle Thesaurus Management System (TMS), Oracle Adverse Event Reporting System (AERS) and Oracle Argus Safety. pharmaSOL is an Oracle Accelerate solution provider for Oracle Health Sciences and a Gold level member in Oracle PartnerNetwork (OPN). The Oracle Accelerate rapidLIVE solution delivered by pharmaSOL allows clients to cost-effectively implement leading commercial life science systems, including Oracle's Health Sciences technology, enabling them to be in production in just a few weeks. This Oracle Accelerate solution is already available in several countries in Europe. rapidLIVE provides an accelerated deployment package, with industry best practice configurations, a streamlined validation test package and in-depth instructor-led modular training. Offered as an affordable fixed-cost solution with flexible licensing, rapidLIVE can be implemented on-premise at the client's site or via the cloud in conjunction with pharmaSOL's hosting/SaaS offering. "We are excited to be able to further our presence in North America. Our innovative technology solutions, such as Oracle Accelerate rapidLIVE, coupled with our team of industry-leading experts, will now provide North American clients the differentiating advantages across Oracle's broad Health Sciences' suite that our European clientele have become accustomed to experiencing over the past 12 years," said Sheldon Wong, pharmaSOL's US-based chief operating officer. "Used by midsize companies around the world, Oracle Accelerate solutions combine Oracle's best-in-class software with our knowledgeable partners to help life science organizations achieve needed industry specific functionality and a quick return on investment," said Steve Cox, vice president, Oracle Accelerate for Midsize Companies." About Oracle Accelerate Oracle Accelerate provides simple to deploy, packaged, enterprise-class software solutions to growing midsize organizations through Oracle's network of expert partners. Created by Oracle's expert partners, Oracle Accelerate solutions are simple to deploy, industry-specific packaged solutions, designed for fast time to benefit, which means getting the right solution in place quickly, inexpensively and with a controlled scope and predictable returns. The best Oracle Accelerate Solutions are based on Oracle Business Accelerators, which are powerful, cloud-based rapid implementation tools developed and maintained by Oracle to get you up and running on a wide range of Oracle Applications, both quickly and reliably. Oracle has more than 290,000 midsize customers who buy Oracle to grow. To find out more, visit www.oracle.com/accelerate. About Oracle PartnerNetwork Oracle PartnerNetwork (OPN) Specialized is the latest version of Oracle's partner program that provides partners with tools to better develop, sell and implement Oracle solutions. OPN Specialized offers resources to train and support specialized knowledge of Oracle products and solutions and has evolved to recognize Oracle's growing product portfolio, partner base and business opportunity. Key to the latest enhancements to OPN is the ability for partners to differentiate through Specializations. Specializations are achieved through competency development, business results, expertise and proven success. To find out more visit http://www.oracle.com/partners. About pharmaSOL pharmaSOL is a leading provider of innovative technology solutions and expert consulting services for the life sciences industry. Providing high quality capabilities to our pharmaceutical, biotechnology, CROs and regulatory partners for over 12 years, we are committed to delivering efficient and practical end-to-end solutions that allow our clients to focus more successfully on their core business needs.